ubmslateRN-logo-ubm

RN Mobile Menu

Search form

Topics:

Osteoporosis

15 Recommendations for Treating Glucocorticoid-Induced Osteoporosis

For the first time in seven years, the ACR has new treatment recommendations for glucocorticoid-induced osteoporosis. (©JavierRegueiro/Shutterstock.com)

Osteoporosis

© Lightspring/Shutterstock.com

Both romosozumab and calcium help fracture prevention, and most young adults have fractures at nonosteoporotic sites.

© BeatePanosch/Shutterstock.com

In the ARCH trial, romosozumab plus alendronate outperformed alendronate alone in reducing fracture risk.

The latest research findings reveal new aspects of diagnosis, treatment, and prevention.

An ICER analysis and expert commentary on anabolics’ benefits and costs offer some opposing views, and some consensus.

Only a minority of postmenopausal women reported using appropriate therapy other than estrogen to reduce future fractures.

Dr. Piet Geusens, Maastricht University, The Netherlands

EULAR 2017: Romosozumab reduces the risk of clinical vertebral fractures in postmenopausal women with osteoporosis by as much as five times.

Osteoporosis (©JavierRegueiro/Shutterstock.com)

For the first time in seven years, the ACR has new treatment recommendations for glucocorticoid-induced osteoporosis. In this slideshow, we highlight the new guidelines.

Pages

Subscribe to Osteoporosis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.